This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,790.00 firm fixed-price delivery order is for the supply of Ozempic, a diabetes medication, with a period of performance through December 24, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order did not utilize any set-aside designations, indicating open competition. The contract aligns with the DLA's mission to provide medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and other essential supplies, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/24/25, 9:54 AM